I've seen perhaps 10 patients like this over the past 6-7 years. All of the events began shortly after decreasing from Brilinta/ASA dual therapy (which is standard for a few months after flow diverter placement) to ASA monotherapy. Like Drew, the exam has been invariably normal and with a benign course, though we've put them all back on dual antiplatelet therapy. The events have almost invariably resolved promptly after resumption of dual antiplatelet therapy and I've had almost no success with verapamil or nifedipine. Usually we've given it 3-6 months and tried to wean antiplatelets again, often with eventual success. I've never obtained a TCD, which could be interesting.
That said, my patients have all had flow diverting stents placed in the ICA proximal to or across the ophthalmic artery's origin, so your patient's situation might be different since it sounds like it's perhaps only the PComm which has the flow diverter.
All the best,
Marc Bouffard
The information in this e-mail is intended only for the person to whom it is addressed. If you believe this e-mail was sent to you in error and the e-mail contains patient information, please contact the Mass General Brigham Compliance HelpLine at https://www.massgeneralbrigham.org/complianceline .
Please note that this e-mail is not secure (encrypted). If you do not wish to continue communication over unencrypted e-mail, please notify the sender of this message immediately. Continuing to send or respond to e-mail after receiving this message means you understand and accept this risk and wish to continue to communicate over unencrypted e-mail.
Original Message:
Sent: 9/3/2025 4:40:00 PM
From: Eric Berman
Subject: RE: flow diverter and retinal ischemia
Thank you both – I have already suggested verapamil as a 1st treatment.
ELB
Original Message:
Sent: 9/3/2025 3:43:00 PM
From: Deborah Friedman
Subject: RE: flow diverter and retinal ischemia
If there is no contraindication, I suggest a calcium channel blocker if vasospasm is suspected (e.g., verapamil).
Deb
Original Message:
Sent: 9/3/2025 2:10:00 PM
From: Andrew Carey
Subject: RE: flow diverter and retinal ischemia
I have a few of these patients with similar symptoms after de-escalation of anti-platelet therapy and have never found anything on exam and patients have not had permanent vision loss, but it is only a handful. I would recommend a fluorescein angiogram to rule out ocular ischemic syndrome (and labs for GCA if in the appropriate age group). If normal, I would chalk it up to vasospasm and consider an anti-migraine medication such as riboflavin, topamax, etc).
Best,
Drew
------------------------------
Andrew Carey
Associate Professor
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore MD
------------------------------
Original Message:
Sent: 09-03-2025 13:31
From: Eric Berman
Subject: flow diverter and retinal ischemia
Good afternoon all,
I have a patient with history of right-sided posterior communicating aneurysm who initially underwent coil embolization and subsequently had pipeline embolization (flow diverter) 1 month later (11/14/24). She had angiogram 5/22/25 which showed no evidence of filling of the previously embolized right posterior communicating artery aneurysm and no evidence of stent complication. She was switched at that time from Brilinta to ASA 81 mg. She is on Eliquis for lower extremity DVT that developed after a 13 hour car ride following her hospital admission.
On 5/31/25 she developed acute loss of vision in the right eye and has now had 8 episodes. 7 of the 8 occurred related to daylight (7 when going from indoors out into the sun and 1 while driving into the sun) and 1 when she woke up in the morning. All have been essentially the same lasting about 15 minutes before abating. Sudden onset and cessation with no other neurologic symptoms at the same time. MRI shows nothing changed from previous with stent in close contact with right optic tract (not optic nerve). I asked the surgeon about this, and he said:
"The stent is not a normal stent, rather a flow diverter (changes the flow across the segment) so in her case it's in the communicating segment and it covers the ophthalmic artery. It's very commonly used. There are case reports on retinal ischemia following flow diversion, but not common. Once the stent is in and endothelialized ( which happens 4-6 weeks after placement), we can't take it out. "
Anyone have any experience with this situation? Ideas on treatment? Her exam while asymptomatic is totally normal as is her VF and OCT.
Thanks in advance for any help you can provide
ELB
Eric L. Berman, MD
Dr. William A. and Sandra F. Johnson Endowed Chair in Neuro-Ophthalmology
Director, Neuro-Ophthalmology Service
Storm Eye Institute
Medical University of South Carolina